Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AAIPharma, CML Appoint API VPs | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

AAIPharma, CML Appoint API VPs

Dolan and Husain to manage API business unit

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Ted Dolan has been appointed vice president of API Operations and Syed T. Husain has been named vice president of the API business unit at AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. (CML).
 
Mr. Dolan recently served as vice president of Global Operations at Johnson Matthey and brings 30 years of operations and management experience in the refining, automotive, fine chemical, and pharmaceutical (API) industries. 
 
Mr. Husain recently served as head of business development and business team at Lonza. He has more than 10 years of experience in sales, business development, marketing and operations.
 
“Mr. Dolan’s experience operating and managing teams in the chemical and pharmaceutical industries will further solidify our leadership in API manufacturing – this is an exciting time for our organization,” said Stephan Kutzer, Ph.D., chief executive officer.
 
Dr. Kutzer added, “Mr. Husain’s diverse experience in both Business Development and Operations will allow us to continue to provide our customers with best-in-class solutions in the API manufacturing industry.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters